Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06111131 · ClinicalTrials.gov registry record · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
A NA study of Small Bowel Disease, sponsored by Aspero Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 5
- Study locations
NCT06111131: Recruiting NA study of Small Bowel Disease, sponsored by Aspero Medical.
NCT06111131 is a NA study of Small Bowel Disease that is actively recruiting participants, run by Aspero Medical. The registered enrollment target is 123 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06111131, a NA study of Small Bowel Disease, is actively recruiting participants, sponsored by Aspero Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 5
- Study locations
Study Summary
Demonstrate superiority of the Aspero Medical Ancora-SB balloon Overtube compared to the Olympus ST-SB1 Balloon Overtube.
Conditions Studied
Interventions
- DEVICE Enteroscopy
Study Locations (5)
Maryland
- University of Maryland - Baltimore
- Johns Hopkins - Baltimore
California
- Cedars Sinai - Los Angeles
Missouri
- Washington University School of Medicine in St. Louis - St Louis
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2025-05-15 |
| Phase | NA |
What NCT06111131 shows while recruiting
NCT06111131 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Small Bowel Disease appearing as the primary indexed condition, and to 1 intervention - of which Enteroscopy is the first listed.
NCT06111131 lists 5 locations in 4 states (Maryland, California, Missouri).
Frequently Asked Questions
What is clinical trial NCT06111131 about?
NCT06111131 is a clinical study titled "Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures". Demonstrate superiority of the Aspero Medical Ancora-SB balloon Overtube compared to the Olympus ST-SB1 Balloon Overtube.
What is the current status of trial NCT06111131?
This trial is currently recruiting. It is a NA study. The enrollment target is 123 participants. The study started on 2024-01-15. Estimated completion is 2025-05-15.
What conditions does trial NCT06111131 study?
This clinical trial studies the following conditions: Small Bowel Disease.
What interventions are being tested in trial NCT06111131?
The interventions under investigation include: Enteroscopy (DEVICE).
Who is sponsoring clinical trial NCT06111131?
This trial is sponsored by Aspero Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06111131 being conducted?
This trial has 5 study locations across California, Maryland, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06111131's enrollment target sits among peer trials
123 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06362252 · 123 participants · Phase 1
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI